Product Description
Tigecycline Injection IP embodies an elite antibiotic solution from the formidable Glycylcycline class, crafted for potent action against complicated bacterial infections. Boasting a flawless formulation, each lyophilized powder vial yields a yellow to orange liquid upon reconstitution with 0.9% sodium chloride or 5% dextrose. Intended for intravenous administration, this prescription-only antibiotic delivers unmatched efficacy against skin, soft tissue, and intra-abdominal infections in adults. Secure access to Tigecycline Injection IP under medical supervision and experience a superior standard in antibacterial defense, marketed by India's leading pharmaceutical companies.
Specialized Usage for Serious Infections
Tigecycline Injection IP is specifically recommended for adults battling complicated skin and soft tissue infections, as well as severe intra-abdominal infections. Administered intravenously, it ensures direct and rapid delivery into the bloodstream for maximum effect. Suitable application media include 0.9% sodium chloride or 5% dextrose solutions for reconstitution. Its precise action makes Tigecycline an elite choice within hospital and clinical settings, guaranteeing potent antibacterial intervention where standard treatments may falter.
Sample Provision, Accredition, and Logistics
Verified samples of Tigecycline Injection IP can be handed over upon request, supporting healthcare professionals in evaluating quality before procurement. Each shipment is supplied with certifications from regulatory agencies, attesting to its safety and potency. Delivered across major domestic markets in India, the product is securely packaged and stored to maintain integrity throughout transit. With reliable supply chains, Tigecycline Injection IP reaches healthcare facilities swiftly and efficiently.
FAQ's of Tigecycline Injection IP:
Q: How is Tigecycline Injection IP administered to patients?
A: Tigecycline Injection IP is administered via intravenous (IV) infusion, after reconstituting the lyophilized powder with 5.3 mL of either 0.9% sodium chloride or 5% dextrose solution as directed by a healthcare professional.
Q: What conditions is Tigecycline Injection IP recommended for?
A: It is indicated for the treatment of complicated skin and soft tissue infections as well as complicated intra-abdominal infections in adults, as prescribed by a physician.
Q: When should the reconstituted Tigecycline Injection IP be used?
A: After reconstitution, the solution should be used within 24 hours if it is refrigerated, ensuring potency and safety are maintained.
Q: Where is Tigecycline Injection IP manufactured and marketed?
A: This elite antibiotic is manufactured and marketed by leading pharmaceutical companies in India, ensuring access to a high-quality, certified product.
Q: What is the process for obtaining a sample of Tigecycline Injection IP?
A: Samples can be requested through authorized suppliers or traders, and will be handed over or delivered as per standard operating procedures, along with necessary certifications.
Q: What are the benefits of using Tigecycline Injection IP for bacterial infections?
A: Tigecycline Injection IP offers potent activity against a wide variety of resistant bacteria, providing a formidable alternative when conventional antibiotics may prove ineffective.
Send Inquiry
Send Inquiry
Send SMS
Call Me Free
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese